Drugmaker GSK returns to growth in China after torrid time

LONDON, Oct 26 (Reuters) - GlaxoSmithKline comments on China during third-quarter results:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.